Abstract: Cyclic redundancy check-aided tail-biting convolutional code (CRC-TBCC) is considered as a competitive candidate for ultra-reliable and low-latency communications (URLLC) in short-length ...
Abstract: In non-cooperative communications, receivers lack prior channel coding knowledge, making error correction code recognition critical. Recursive systematic ...
Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback